Evidence map›Paper›PMID 20144422›Full record

ArticleJournal of diabetes science and technology2009

Run-to-run tuning of model predictive control for type 1 diabetes subjects: in silico trial.

Lalo Magni, Marco Forgione, Chiara Toffanin, Chiara Dalla Man, Boris Kovatchev, Giuseppe De Nicolao, Claudio Cobelli

Abstract read
In one paragraph

Article in Journal of diabetes science and technology, 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

23 citing papers in PubMed.

  1. Trial
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Model-based sensor-augmented pump therapy.Journal of diabetes science and technology · 2013
    Article
  13. Wearable and implantable pancreas substitutes.Journal of artificial organs : the official journal of the Japanese Society for Artificial Organs · 2013
    Review
  14. Article
  15. Modular closed-loop control of diabetes.IEEE transactions on bio-medical engineering · 2012
    Article
  16. Review
  17. The artificial pancreas.Diabetes · 2012
    Article
  18. Review
  19. AP@home: a novel European approach to bring the artificial pancreas home.Journal of diabetes science and technology · 2011
    Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Lalo MagniDipartimento di Informatica e Sistemistica, University of Pavia, Pavia, Italy.
Marco Forgione
Chiara Toffanin
Chiara Dalla Man
Boris Kovatchev
Giuseppe De Nicolao
Claudio Cobelli

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThe technological advancements in subcutaneous continuous glucose monitoring and insulin pump delivery systems have paved the way to clinical testing of artificial pancreas devices. The experience derived by clinical trials poses technological challenges to the automatic control expert, the most notable being the large interpatient and intrapatient variability and the inherent uncertainty of patient information.

methodsA new model predictive control (MPC) glucose control system is proposed. The starting point is an MPC algorithm applied in 20 type 1 diabetes mellitus (T1DM) subjects. Three main changes are introduced: individualization of the ARX model used for prediction; synthesis of the MPC law on top of the open-loop basal/bolus therapy; and a run-to-run approach for implementing day-by-day tuning of the algorithm. In order to individualize the ARX model, a sufficiently exciting insulin profile is imposed by splitting the premeal bolus into two smaller boluses (40% and 60%) injected 30 min before and 30 min after the meal.

resultsThe proposed algorithm was tested on 100 virtual subjects extracted from an in silico T1DM population. The trial simulates 44 consecutive days, during which the patient receives breakfast, lunch, and dinner each day. For 10 days, meals are multiplied by a random variable uniformly distributed in [0.5, 1.5], while insulin delivery is based on nominal meals. Moreover, for 10 days, either a linear increase or decrease of insulin sensitivity (+/-25% of nominal value) is introduced.

conclusionsThe ARX model identification procedure offers an automatic tool for patient model individualization. The run-to-run approach is an effective way to auto-tune the aggressiveness of the closed-loop control law, is robust to meal variation, and is also capable of adapting the regulator to slow parameter variations, e.g., on insulin sensitivity.

Indexed as

AlgorithmsInsulin Infusion SystemsPancreas, ArtificialBlood GlucoseBlood Glucose Self-MonitoringComputer SimulationDiabetes Mellitus, Type 1Diagnosis, Computer-AssistedDietary CarbohydratesDrug Therapy, Computer-AssistedHumansHypoglycemic AgentsInsulinModels, BiologicalModels, StatisticalPredictive Value of TestsBlood GlucoseDietary CarbohydratesHypoglycemic AgentsInsulin

Identifiers

PMID20144422
PMCPMC2769897

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.